From: Application of Glutamine-enriched nutrition therapy in childhood acute lymphoblastic leukemia
Parameters | n | ALB (g/L) | PA (mg/L) | RBP (mg/L) | UHI | CHI |
---|---|---|---|---|---|---|
Treatment group | 24 | |||||
Before treatment | 29.45 ± 2.87 | 106.6 ± 21.58 | 19.56 ± 1.78 | 1.38 ± 0.48 | 75.96 ± 11.69 | |
At the end of 1st week | 29.34 ± 3.53 | 107.5 ± 22.47 | 19.42 ± 1.94 | 1.39 ± 0.55 | 76.21 ± 12.15 | |
At the end of 2nd week | 28.69 ± 2.72 | 113.47 ± 20.56a | 21.76 ± 1.89a | 1.35 ± 0.51 | 72.54 ± 13.21 | |
At the end of 3rd week | 30.78 ± 2.75a | 130.52 ± 22.31a | 22.34 ± 2.15a | 1.42 ± 0.55a | 75.88 ± 14.16 | |
At the end of 4th week | 32.57 ± 3.05a | 145.71 ± 23.25a | 24.59 ± 5.30a | 1.49 ± 0.57a | 78.22 ± 14.57 | |
Control group | 24 | |||||
Before treatment | 29.34 ± 3.67 | 111.78 ± 21.23 | 20.57 ± 2.32 | 1.29 ± 0.51 | 75.79 ± 12.33 | |
At the end of 1st week | 29.11 ± 3.42 | 110.44 ± 20.54 | 20.13 ± 2.02 | 1.28 ± 0.46 | 75.59 ± 12.08 | |
At the end of 2nd week | 28.77 ± 3.09 | 100.85 ± 19.78 | 19.78 ± 2.11 | 1.26 ± 0.41 | 73.14 ± 12.79 | |
At the end of 3rd week | 26.90 ± 3.54 | 112.62 ± 20.01 | 20.05 ± 2.52 | 1.15 ± 0.38 | 72.21 ± 12.58 | |
At the end of 4th week | 27.15 ± 3.29 | 110.57 ± 21.22 | 19.52 ± 2.49 | 1.18 ± 0.36 | 72.75 ± 12.93 |